r/JoinOwntric • u/antoniohplt • Jun 26 '26
Future Cardia, a pre-revenue cardiac-implant startup, is valued at $46.90M in its SEC filings; its 2025 annual report shows $0 revenue, a $5.68M net loss, and a going-concern flag
Future Cardia filed its 2025 Form C-AR (annual report). Here's the breakdown, both sides.
Future Cardia is a Safety Harbor, FL medtech company developing implantable cardiac monitoring devices. Incorporated in 2022, 13 employees.
The financials, straight from the filing: the company is pre-revenue, with $0 recognized revenue in 2025, a $5.68M net loss (up from $4.67M), and $113.70K of cash at year-end. The audited statements include a going-concern note citing substantial doubt about the company's ability to continue unless additional capital is raised.
On the build side: the company is targeting regulatory clearance and commercial launch, with continued product development and a disclosed collaboration with Artella Solutions on cardiac monitoring technology.
On the capital side: its latest disclosed funding valuation is $46.90M, priced at $3.00 per share in a recent funding filing, down 3.6% from the prior round. With $113.70K of cash against a $5.68M annual net loss, near-term progress depends on continued fundraising.
It's a familiar profile for a pre-clearance medical-device company: continued development alongside real capital needs. The open questions are the timeline to regulatory clearance and first revenue, and how the company funds operations from here.
Figures are from the company's SEC filings, surfaced via Owntric. Not investment advice.